The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines
Open accessAbstract
Immunological memory is the basis of protective immunity provided by vaccines and previous infections. Immunological memory can develop from multiple branches of the adaptive immune system, including CD4 T cells, CD8 T cells, B cells, and long‐lasting antibody responses. Extraordinary progress has been made in understanding memory to SARS‐CoV‐2 infection and COVID‐19 vaccines, addressing development; quantitative and qualitative features of different cellular and anatomical compartments; and durability of each cellular component and antibodies. Given the sophistication of the measurements; the size of the human studies; the use of longitudinal samples and cross‐sectional studies; and head‐to‐head comparisons between infection and vaccines or between multiple vaccines, the understanding of immune memory for 1 year to SARS‐CoV‐2 infection and vaccines already supersedes that of any other acute infectious disease. This knowledge may help inform public policies regarding COVID‐19 and COVID‐19 vaccines, as well as the scientific development of future vaccines against SARS‐CoV‐2 and other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
Immunity to SARS-CoV-2 up to 15 months after infection
Marcotte, H., Piralla, A., Zuo, F., Du, L., Cassaniti, I., Wan, H., Kumagai‐Braesch, M., Andréll, J., Percivalle, E., Sammartino, J. C., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103743 · Cited by 85
Quantitating T Cell Cross-Reactivity for Unrelated Peptide Antigens
Ishizuka, J. J., Grebe, K. M., Shenderov, E., Peters, B., Chen, Q., Peng, Y., Wang, L., Dong, T., Pasquetto, V., Oseroff, C., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901607 · Cited by 84
Self-citationCollier, A.-R. Y., Brown, C., McMahan, K., Yu, J., Liu, J., Jacob-Dolan, C., Chandrashekar, A., Tierney, D. B., Ansel, J. L., Rowe, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn6150 · Cited by 78
Li, C., Yu, D., Wu, X. J., Hong, L., Zhou, Z., Xie, Y., Li, T., Wu, J., Lu, F., Feng, L. Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24230-5 · Cited by 76
Li, C., Yu, D., Wu, X., Liang, H., Zhou, Z., Xie, Y., Li, T., Wu, J., Lu, F., Feng, L., et al. (2021) · doi:10.1101/2021.04.05.437224 · Cited by 73
Quadeer, A. A., Ahmed, S. F., & McKay, M. R. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100312 · Cited by 72
Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
Wragg, K. M., Lee, W. S., Koutsakos, M., Tan, H., Amarasena, T. H., Reynaldi, A., Gare, G., Konstandopoulos, P., Field, K. R., Esterbauer, R., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01175-5 · Cited by 71
Antunes, R. D. S., Pallikkuth, S., Williams, E., Yu, E. D., Mateus, J., Quiambao, L. G., Wang, E. W., Rawlings, S. A., Stadlbauer, D., Jiang, K., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab176 · Cited by 70
Self-citationGrifoni, A., Voic, H., Dhanda, S. K., Kidd, C. K., Brien, J. D., Buus, S., Stryhn, A., Durbin, A. P., Whitehead, S. S., Diehl, S. A., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00089-20 · Cited by 68
Self-citationHeterogeneity of human anti-viral immunity shaped by virus, tissue, age, and sex
Poon, M. M. L., Byington, E., Meng, W., Kubota, M., Matsumoto, R., Grifoni, A., Weiskopf, D., Dogra, P., Lam, N., Szabo, P. A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110071 · Cited by 65
Self-citationLeidi, A., Koegler, F., Dumont, R., Dubos, R., Zaballa, M.-E., Piumatti, G., Coen, M., Berner, A., Farhoumand, P. D., Vetter, P., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab495 · Cited by 62
Vikkurthi, R., Ansari, A., Pai, A. R., Jha, S. N., Sachan, S., Pandit, S., Nikam, B., Kalia, A., Jit, B. P., Parray, H. A., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01161-5 · Cited by 62
Self-citationGarg, S., Patel, K., Pham, H., WHITAKER, M. D., O’Halloran, A. C., Milucky, J., Anglin, O., Kirley, P. D., Reingold, A. L., Kawasaki, B., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1991 · Cited by 60
Kaneko, N., Boucau, J., Kuo, H.-H., Perugino, C. A., Mahajan, V. S., Farmer, J. R., Liu, H., Diefenbach, T. J., Trocha, A. K., Lefteri, K., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.108991 · Cited by 60
Do Memory CD4 T Cells Keep Their Cell-Type Programming: Plasticity versus Fate Commitment?Preprint
Crotty, S. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032102 · Cited by 59
Self-citationIshii, H., Nomura, T., Yamamoto, H., Nishizawa, M., Hau, T. T. T., Harada, S., Seki, S., Nakamura‐Hoshi, M., Okazaki, M., Daigen, S., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100520 · Cited by 59
Khoo, N. K. H., Lim, J. M. E., Gill, U. S., de Alwis, R., Tan, N., Toh, J. Z. N., Abbott, J. E., Usai, C., Ooi, E. E., Low, J. G. H., et al. (2022) · Med · doi:10.1016/j.medj.2021.12.004 · Cited by 51
Prior Presumed Coronavirus Infection Reduces COVID-19 Risk: A Cohort Study
Aran, D., Beachler, D. C., Lanes, S., & Overhage, J. M. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.10.023 · Cited by 45
Tarke, A., Coelho, C. H., Zhang, Z., Dan, J. M., Yu, E. D., Methot, N., Bloom, N. I., Goodwin, B., Phillips, E. J., Mallal, S. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.28.474333 · Cited by 42
Self-citationIncreased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine DosePreprint
Muecksch, F., Wang, Z., Cho, A., Gaebler, C., Tanfous, T. B., DaSilva, J., Bednarski, E., Ramos, V., Zong, S., Johnson, B. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.14.480394 · Cited by 41
Dobaño, C., Alonso, S., Vidal, M., Jiménez, A., Rubio, R., Santano, R., Barrios, D., Pons-Tomàs, G., Melé-Casas, M., Hernández, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.751705 · Cited by 29
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection
Gombar, S., Bergquist, T., Pejaver, V. R., Hammarlund, N. E., Murugesan, K., Mooney, S. D., Shah, N. H., Pinsky, B. A., & Banaei, N. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115338 · Cited by 27
Bert, N. L., Chia, W. N., Wan, W. Y., Teo, A. K. J., Chong, S. Z. R., Tan, N., Tan, D. S. C., Chia, A., Tan, I. B., Kunasegaran, K., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1999777 · Cited by 23
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset
Law, J. C., Girard, M., Chao, G. Y. C., Ward, L. A., Isho, B., Rathod, B., Colwill, K., Li, Z., Rini, J. M., Yue, F. Y., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100727 · Cited by 23
Singh, V., Obregon-Perko, V., Lapp, S. A., Horner, A. M., Brooks, A. D., Macoy, L., Hussaini, L., Lu, A., Gibson, T., Silvestri, G., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.155145 · Cited by 22
Self-citationConway, S. R., Lazarski, C. A., Field, N. E., Jensen-Wachspress, M. A., Lang, H., Kankate, V. V., Durkee-Shock, J. R., Kinoshita, H., Suslovic, W., Webber, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.793197 · Cited by 21
Kannenberg, J., Trawinski, H., Henschler, R., Buhmann, R., Hönemann, M., & Jassoy, C. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac034 · Cited by 20
Meyer-Arndt, L., Schwarz, T., Loyal, L., Henze, L., Kruse, B., Dingeldey, M., Gürcan, K., Uyar-Aydin, Z., Müller, M., Drosten, C., et al. (2022) · Journal of Immunology · doi:10.4049/jimmunol.2100990 · Cited by 19
Hsieh, L., Grifoni, A., Sidney, J., Shimizu, C., Shike, H., Ramchandar, N., Moreno, E., Tremoulet, A. H., Burns, J. C., & Franco, A. (2021) · European Journal of Immunology · doi:10.1002/eji.202149556 · Cited by 18
Germinal centre-driven maturation of B cell response to SARS-CoV-2 vaccinationPreprint
Kim, W., Zhou, J. Q., Sturtz, A. J., Horvath, S. C., Schmitz, A. J., Lei, T., Kalaidina, E., Thapa, M., Alsoussi, W. B., Haile, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.31.466651 · Cited by 18
Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccinePreprint
Xia, H., Zou, J., Kurhade, C., Cai, H., Yang, Q., Cutler, M. W., Cooper, D., Muik, A., Jansen, K. U., Xie, X., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.21.476344 · Cited by 15
Gaebler, C., DaSilva, J., Bednarski, E., Muecksch, F., Schmidt, F., Weisblum, Y., Millard, K. G., Turroja, M., Cho, A., Wang, Z., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac227 · Cited by 7
Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral controlPreprint
Dong, T., Liu, G., Felce, S. L., Yao, X., Yin, Z., Fries, A., Mentzer, A. J., Dong, D., Wang, W., Dejnirattisai, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1317569/v1 · Cited by 3
Sajadi, M. M., Myers, A., Logue, J., Saadat, S., Shokatpour, N., Quinn, J., Newman, M., Deming, M., Tehrani, Z. R., Karimi, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.13.472159 · Cited by 2
Self-citation
Cited by
PANoptosis: Mechanisms, biology, and role in disease
Sun, X., Yang, Y., Meng, X., Li, J., Liu, X., & Liu, H. (2024) · Immunological Reviews · doi:10.1111/imr.13279 · Cited by 305
Lim, J. M. E., Hang, S. K., Hariharaputran, S., Chia, A., Tan, N., Lee, E. S., Chng, E., Lim, P. L., Young, B. E., Lye, D. C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100793 · Cited by 73
Chen, X., Zhao, J., Yue, S., Li, Z., Duan, X., Lin, Y., Yang, Y., He, J., Gao, L., Pan, Z., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00760-x · Cited by 68
Metadata
- Authors
- Sette, A., & Crotty, S.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2022-06-22
- Volume
- 310
- Issue
- 1
- Pages
- 27-46
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W4283331044
- Cited by
- 269
- References
- 234
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.